Taylorella equigenitalis and Contagious Equine Metritis (CEM): Quarantine and Diagnosis

Introduction

Contagious equine metritis (CEM) is a highly transmissible venereal disease of horses caused by the Gram-negative coccobacillus Taylorella equigenitalis. First recognized in the 1970s, CEM remains a notifiable disease in many jurisdictions and imposes stringent international movement restrictions on breeding stock. The pathogen is capable of establishing asymptomatic carrier states in stallions and some mares, complicating eradication efforts. Accurate diagnosis, effective quarantine, and molecular epidemiological surveillance are essential cornerstones of CEM control. This article provides a detailed technical review of T. equigenitalis biology, the pathogenesis of CEM, and current best practices for laboratory diagnosis and quarantine management, drawing on recent genomic and diagnostic advances [1-46].

Etiology and Taxonomy

Taylorella equigenitalis belongs to the family Alcaligenaceae within the Betaproteobacteria. The bacterium is a fastidious, microaerophilic, Gram-negative rod that requires enriched media (e.g., chocolate agar) for primary isolation [1]. It is distinguished from its close relative Taylorella asinigenitalis, which primarily colonizes donkeys and has been reported in several donkey breeds globally [2, 3, 4, 5, 6]. Genomic analyses have revealed the presence of genomic islands (GIs) that may contribute to host adaptation and virulence [7]. Whole-genome sequencing (WGS) has been instrumental in resolving phylogenetic relationships: a molecular dating study suggested that the most recent common ancestor of Czech T. equigenitalis strains dated to the Roman Empire period [8, 9]. The species exhibits considerable genomic diversity, as demonstrated by multi-locus sequence typing (MLST) and core-genome MLST (cgMLST) schemes [10, 11, 12, 46].

Taylorella asinigenitalis and Differential Considerations

T. asinigenitalis is a closely related species that can cause similar clinical signs in mares and has been isolated from donkeys and horses [2, 3, 4, 5, 6]. Some strains of T. asinigenitalis exhibit differing pathogenicity, with one study showing reduced virulence in mares compared to jenny donkeys [6]. The two species can be differentiated by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) using expanded reference spectra [30] and by specific molecular assays [13, 41].

Epidemiology and Global Distribution

CEM is distributed worldwide, with sporadic outbreaks and endemic pockets reported in Europe, North America, South Africa, and Asia. The horse is the primary reservoir; stallions are often asymptomatic carriers, harboring the organism in the urethral fossa, penile sheath, and seminal fluid [14, 15]. Mares can become infected during natural cover or artificial insemination with contaminated semen [16]. The bacterium can survive in chilled and cryopreserved semen, representing a major route of international spread [14, 16].

Surveillance data from various countries demonstrate ongoing circulation. In Germany and Austria, a study of Icelandic mares and geldings detected T. equigenitalis DNA in a proportion of animals, indicating subclinical carriage [17, 18]. Polish diagnostic investigations have confirmed infections in breeding stock [19]. French outbreaks have been documented since 2006 [38], and French proficiency testing programs highlight the importance of harmonized real-time PCR methods [20, 33]. In the United States, genomic analysis of strains introduced between 1978 and 2012 revealed multiple introduction events [34]. South African studies have used PCR-based national surveillance to map prevalence [42] and direct culture-independent sequence typing from swabs and semen [21]. The global distribution inferred by MLST shows that certain sequence types are widely disseminated [12].

The detection of T. equigenitalis in Icelandic horses kept in Southern Germany and Austria underscores the role of apparently healthy carrier animals in maintaining the pathogen [17, 18]. Furthermore, studies on survival of Taylorella spp. indicate that the bacterium can persist in straw-based bedding for limited periods [22] and can survive within environmental amoebae such as Acanthamoeba castellanii, suggesting a potential environmental reservoir [45].

Clinical Signs and Pathology

In mares, the classic presentation of CEM is an acute mucopurulent endometritis occurring 2 to 14 days after breeding. Clinical signs include a copious, grayish-white vaginal discharge, vaginitis, cervicitis, and variable infertility. The discharge is often non-odorous. Some mares develop only mild endometritis or remain subclinical carriers, especially those previously infected. Stallions show no overt clinical signs but serve as long-term carriers. The pathological hallmark is an acute, suppurative inflammation of the endometrium, with neutrophilic infiltration and desquamation of epithelial cells. In experimental infections, the bacterium adheres to the equine endometrial epithelium and elicits a localized inflammatory response. The carrier state in mares may involve persistence of the organism in the clitoral sinuses and fossa.

In donkeys, T. asinigenitalis can cause similar signs, but some strains appear to be less pathogenic in mares [6]. Cases of acute endometritis due to T. equigenitalis transmission via cryopreserved stallion semen have been documented [16].

Diagnosis

Accurate diagnosis of CEM relies on a combination of bacterial culture, nucleic acid amplification tests (NAATs), and confirmatory characterization. The World Organisation for Animal Health (WOAH) recommends culture as the gold standard, but real-time PCR is now widely used as a primary screening tool due to its higher sensitivity and faster turnaround.

Sample Collection and Transport

Genital swabs are the sample of choice. For stallions, samples are collected from the urethral fossa, penile sheath, and pre-ejaculatory fluid. For mares, swabs are taken from the endometrium (via cytology brush or guarded swab) and clitoral sinuses. The use of "dry" swabs has been shown to enhance detection by qPCR compared to swabs placed in transport medium [23]. However, preservation of viable organisms for culture requires specialized transport systems; a study evaluated several commercially available systems and found significant differences in recovery rates [24]. Pooling of genital swabs for PCR testing can increase throughput without appreciable loss of sensitivity [32].

Bacterial Culture

Isolation of T. equigenitalis requires selective chocolate agar incubated at 35-37°C in a microaerophilic atmosphere (5-10% CO₂) for up to 7 days. Several basal compositions have been compared; the choice of selective antibiotics (e.g., amphotericin B, vancomycin, trimethoprim) critically affects recovery [1]. Colonies are small (0.5-1 mm diameter), convex, grayish, and non-hemolytic. Presumptive identification is based on Gram stain morphology, oxidase and catalase positivity, and lack of growth on MacConkey agar. Confirmatory identification can be achieved by MALDI-TOF MS [25, 30] or species-specific PCR.

Molecular Diagnostics

Real-time PCR (qPCR) targeting conserved genes (e.g., 16S rRNA, grol, or unique SNPs) is the most sensitive and specific method for detecting T. equigenitalis directly from swabs and semen [23, 20, 26, 33, 39]. Multiple commercial and in-house assays exist; a comparison of seven different NAATs showed variable performance, emphasizing the need for validated protocols [27]. Multiplex qPCR assays can simultaneously detect T. equigenitalis, T. asinigenitalis, and other equine venereal pathogens [13, 26]. A triplex assay validated by Léon et al. includes targets for T. equigenitalis, Klebsiella pneumoniae, and Pseudomonas aeruginosa [26].

Loop-mediated isothermal amplification (LAMP) assays have also been developed for field-deployable detection [41]. More recently, CRISPR-based detection methods have been explored [40].

Pooling of swabs for PCR is practical for surveillance, and a validation study reported high sensitivity and specificity compared to individual testing [32]. Proficiency testing programs in France have demonstrated the importance of inter-laboratory harmonization for qPCR [20, 33].

Serology

Complement fixation tests and ELISAs have been developed, but serology is not recommended for routine diagnosis due to inconsistent antibody responses. Serological methods are more useful for retrospective herd surveys and epidemiological studies.

MALDI-TOF MS

MALDI-TOF MS offers rapid, low-cost identification of cultured isolates. An expanded custom reference database improves discrimination between T. equigenitalis and T. asinigenitalis [30]. Studies have shown high accuracy when the database includes sufficient spectral diversity [25].

Genotyping and Molecular Epidemiology

Several typing methods have been applied to T. equigenitalis. Pulsed-field gel electrophoresis (PFGE) and repetitive extragenic palindromic PCR (REP-PCR) were used to genotype German and Austrian isolates [36]. MLST schemes based on housekeeping genes provide a standardized method for global comparison [12, 46]. More recently, cgMLST schemes have been developed for high-resolution epidemiological investigations [10, 11]. Whole-genome sequencing is increasingly used to track transmission chains and identify antimicrobial resistance determinants [8, 28, 9, 31, 34, 37, 43].

Diagnostic Workflow

The following Mermaid diagram illustrates a typical diagnostic pathway for suspected CEM:

flowchart TD
    A[Sample collection: genital swabs, semen], > B{Culture vs. PCR selection}
    B, >|Primary screening| C[Real-time PCR (validated assay)]
    B, >|Gold standard| D[Bacterial culture on selective chocolate agar]
    C, >|Positive| E[Confirmatory culture + MALDI-TOF/sequencing]
    C, >|Negative| F[Report negative / No CEM]
    D, >|Colonies present| G[MALDI-TOF MS or PCR confirmation]
    D, >|No growth after 7 days| F
    G, > H[Genotyping: MLST, cgMLST, or WGS]
    H, > I[Epidemiological investigation and quarantine decisions]
    E, > H

Table 1. Comparison of diagnostic methods for Taylorella equigenitalis.

Quarantine and Control

Quarantine is the primary measure to prevent introduction and spread of CEM. International movement of horses for breeding requires certification of freedom from T. equigenitalis based on testing of both mare and stallion within a specified pre-export period. The following principles apply:

• Stallions entering a breeding facility must be tested by culture and/or PCR on two separate occasions at least 7 days apart, with negative results.
• Mares intended for breeding should be tested from clitoral sinuses and endometrium (if bred) before or after arrival.
• Infected animals are isolated immediately. Treatment or culling is considered.
• Semen from infected or untested stallions must not be used for artificial insemination.
• Quarantine duration is typically a minimum of 60 days after the last positive test and after completion of treatment, with subsequent retesting.
• Countries with endemic CEM may impose additional import conditions, including health certificates and quarantine at the border.

The genomic diversity of T. equigenitalis has implications for quarantine: different sequence types may vary in transmissibility, but all are considered pathogenic and subject to control measures. The emergence of antimicrobial resistance, as noted in T. asinigenitalis isolates from donkeys [2], underscores the need for susceptibility testing when treatment is attempted.

Treatment

Antibiotic therapy is indicated for infected mares and stallions, although stallion carrier elimination is difficult. Local treatment with disinfectant washes (e.g., chlorhexidine) combined with systemic antibiotics based on susceptibility testing is recommended. Commonly used antibiotics include ceftiofur, gentamicin, and trimethoprim-sulfonamides. However, antimicrobial resistance has been reported; comprehensive surveillance using genomic approaches is warranted [2, 28]. Treatment should be followed by repeated negative tests before the animal is released from quarantine.

Conclusion

Contagious equine metritis remains a significant threat to equine breeding industries worldwide. The combination of bacterial culture and real-time PCR provides the most reliable diagnostic framework, while genomic typing tools have greatly enhanced epidemiological understanding. Stringent quarantine protocols and international harmonization of diagnostic standards are essential to prevent reintroduction and to support eradication. Continued surveillance, particularly for emerging antimicrobial resistance and the role of T. asinigenitalis, will inform future control strategies.

References

[1] Breuil MF, Joseph M, Petry S. Comparison of five basal compositions of selective chocolate agar media for isolation of Taylorella equigenitalis. J Equine Vet Sci. 2022. https://pubmed.ncbi.nlm.nih.gov/34871752/

[2] Breuil MF, Duquesne F, Magoga J, et al. Prevalence, genomic diversity and emerging antimicrobial resistance of Taylorella asinigenitalis in Grand Noir du Berry breeding donkeys. Vet Microbiol. 2026. https://pubmed.ncbi.nlm.nih.gov/42275732/

[3] Kozak S, Merda D, Duquesne F, et al. Whole genome sequence analysis of the 2018 Persian onager isolate suggests sublineages within the Taylorella asinigenitalis species. Vet Microbiol. 2023. https://pubmed.ncbi.nlm.nih.gov/37832214/

[4] Dorrego A, Herranz C, Pérez-Sancho M, et al. First report and molecular characterization of cases of natural Taylorella asinigenitalis infection in three donkey breeds in Spain. Vet Microbiol. 2023. https://pubmed.ncbi.nlm.nih.gov/36481483/

[5] Dorrego A, Serres C, Cruz-Lopez F. Taylorella asinigenitalis: raising awareness of its importance and presence in equine and asinine populations. Vet Rec. 2022. https://pubmed.ncbi.nlm.nih.gov/35303356/

[6] Wilsher S, Omar H, Ismer A, et al. A new strain of Taylorella asinigenitalis shows differing pathogenicity in mares and Jenny donkeys. Equine Vet J. 2021. https://pubmed.ncbi.nlm.nih.gov/33174229/

[7] Hicks J, Li G, Petry S, et al. Initial identification of genomic islands in Taylorella equigenitalis and Taylorella asinigenitalis and their distribution in isolates from around the world. BMC Microbiol. 2026. https://pubmed.ncbi.nlm.nih.gov/42249275/

[8] Hrala M, Andrla P, Bosák J, et al. Correction: Whole genome sequences of nine Taylorella equigenitalis strains isolated in the Czech Republic between 1982-2021: Molecular dating suggests a common ancestor at the time of Roman Empire. PLoS One. 2026. https://pubmed.ncbi.nlm.nih.gov/41770708/

[9] Hrala M, Andrla P, Bosák J, et al. Whole genome sequences of nine Taylorella equigenitalis strains isolated in the Czech Republic between 1982-2021: Molecular dating suggests a common ancestor at the time of Roman Empire. PLoS One. 2025. https://pubmed.ncbi.nlm.nih.gov/39752466/

[10] Kozak S, Merda D, Chesnais V, et al. Core genome multilocus sequence typing schemes for epidemiological investigation of Taylorella equigenitalis and Taylorella asinigenitalis. Vet Microbiol. 2025. https://pubmed.ncbi.nlm.nih.gov/39904078/

[11] Pelkola K, Heinikainen S, Pohjanvirta T. Core genome multilocus sequence typing analysis of Finnish Taylorella equigenitalis isolates. Vet Microbiol. 2023. https://pubmed.ncbi.nlm.nih.gov/37633060/

[12] Duquesne F, Merlin A, Pérez-Cobo I, et al. Overview of spatio-temporal distribution inferred by multi-locus sequence typing of Taylorella equigenitalis isolated worldwide from 1977 to 2018 in equidae. Vet Microbiol. 2020. https://pubmed.ncbi.nlm.nih.gov/32122601/

[13] Kim SH, Lee JS, Lee JH, et al. Development and Application of a Multiplex Real-Time Polymerase Chain Reaction Assay for the Simultaneous Detection of Bacterial Aetiologic Agents Associated With Equine Venereal Diseases. J Equine Vet Sci. 2021. https://pubmed.ncbi.nlm.nih.gov/34607681/

[14] Mawhinney I, Davis N, Carson T, et al. Screening for Taylorella equigenitalis in Equine Semen: An Exploratory Study. J Equine Vet Sci. 2022. https://pubmed.ncbi.nlm.nih.gov/36244608/

[15] Quiñones-Pérez C, Martínez A, Crespo F, et al. Comparative Semen Microbiota Composition of a Stallion in a Taylorella equigenitalis Carrier and Non-Carrier State. Animals (Basel). 2020. https://pubmed.ncbi.nlm.nih.gov/32429567/

[16] Delerue M, Breuil MF, Duquesne F, et al. Acute Endometritis due to Taylorella equigenitalis Transmission by Insemination of Cryopres

[17] Solbach V, Grabatin M, Zablotski Y, et al. Prevalence of Taylorella equigenitalis in Icelandic mares and geldings in Southern Germany and Austria. J Equine Vet Sci. 2025. https://pubmed.ncbi.nlm.nih.gov/39622457/

[18] Grabatin M, Fux R, Zablotski Y, et al. Taylorella equigenitalis in Icelandic intact males compared with other horse breeds using natural cover. Equine Vet J. 2025. https://pubmed.ncbi.nlm.nih.gov/39031711/

[19] Wasiński B, Złotnicka J, Kubajka M, et al. Taylorella equigenitalis infections in Poland - results of current diagnostic investigations. J Vet Res. 2025. https://pubmed.ncbi.nlm.nih.gov/41064404/

[20] Petry S, Breuil MF, Duquesne F. Surveillance of Contagious Equine Metritis: Results of the First 5-Year Period of French Proficiency Tests for Taylorella equigenitalis Detection by Real-Time PCR. J Equine Vet Sci. 2023. https://pubmed.ncbi.nlm.nih.gov/36796741/

[21] May CE, Guthrie AJ, Schulman ML. Direct culture-independent sequence typing of Taylorella equigenitalis obtained from genital swabs and frozen semen samples from South African horses. J Vet Diagn Invest. 2019. https://pubmed.ncbi.nlm.nih.gov/31423914/

[22] Florianova M, Krzyzankova M, Korena K, et al. Growth kinetics of Taylorella equigenitalis and its survival in straw-based bedding. Vet Res Commun. 2026. https://pubmed.ncbi.nlm.nih.gov/42154103/

[23] Mawhinney I, Bollard A. Enhanced detection of Taylorella equigenitalis by qPCR using 'Dry' swabs. J Equine Sci. 2023. https://pubmed.ncbi.nlm.nih.gov/37155493/

[24] Duquesne F, Breuil MF, Hans A, et al. Preservation of viable Taylorella equigenitalis in different commercially available transport systems. Vet J. 2021. https://pubmed.ncbi.nlm.nih.gov/33641806/

[25] Uchida-Fujii E, Niwa H, Kinoshita Y, et al. Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry (MALDI-TOF MS) for Identification of Bacterial Isolates From Horses. J Equine Vet Sci. 2020. https://pubmed.ncbi.nlm.nih.gov/33276932/

[26] Léon A, Versmisse Y, Despois L, et al. Validation of an Easy Handling Sample Preparation and Triplex Real Time PCR for Rapid Detection of T. equigenitalis and Other Organisms Associated with Endometritis in Mares. J Equine Vet Sci. 2020. https://pubmed.ncbi.nlm.nih.gov/33077078/

[27] Kinoshita Y, Kakoi H, Ishige T, et al. Comparison of seven nucleic acid amplification tests for detection of Taylorella equigenitalis. J Vet Med Sci. 2022. https://pubmed.ncbi.nlm.nih.gov/34853198/

[28] Harpke M, Brangsch H, Melzer F. Genomic insights into the epidemiology of Contagious Equine Metritis in Germany. Vet Microbiol. 2026. https://pubmed.ncbi.nlm.nih.gov/41411925/

[29] Mawhinney I. Ten years of Taylorella equigenitalis ring trial results comparing culture and polymerase chain reaction. Rev Sci Tech. 2020. https://pubmed.ncbi.nlm.nih.gov/35275139/